GLP-1/GIP/PanPPAR quintuple agonist (Helmholtz Zentrum München)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameGLP-1/GIP/PanPPAR quintuple agonist (Helmholtz Zentrum München)

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsPeroxisome proliferator activated receptor agonists

TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorPeroxisome proliferator activated receptor

Therapy Area/IndicationsObesityDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHelmholtz Zentrum München

China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz Zentrum München

Inactive CompaniesN/A

Active IndicationsObesityDiabetes Mellitus

Inactive IndicationsN/A

Other Information

ATC CodeN/A